Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseases

[1]  T. Hishikawa,et al.  Combined gene therapy with vascular endothelial growth factor plus apelin in a chronic cerebral hypoperfusion model in rats. , 2017, Journal of neurosurgery.

[2]  Lanfang Li,et al.  Apelin/APJ system: A novel promising therapy target for pathological angiogenesis. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[3]  Bo Bai,et al.  Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential , 2017, Front. Mol. Neurosci..

[4]  J. Rafols,et al.  Omega-3 fatty acid supplement prevents development of intracranial atherosclerosis , 2016, Neuroscience.

[5]  Jian-hua Cheng,et al.  Five-year experience of 101 adult patients with moyamoya disease at a single institution in Eastern China , 2016, Journal of Clinical Neuroscience.

[6]  Kazumichi Yoshida,et al.  Histopathological Characteristics of Distal Middle Cerebral Artery in Adult and Pediatric Patients with Moyamoya Disease , 2016, Neurologia medico-chirurgica.

[7]  Seung-Chyul Hong,et al.  Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease , 2016, International journal of stroke : official journal of the International Stroke Society.

[8]  Jong S. Kim.  Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis , 2016, Journal of stroke.

[9]  Lanfang Li,et al.  Apelin/APJ signaling in hypoxia-related diseases. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[10]  Ling Wei,et al.  Intranasal Delivery of Apelin-13 Is Neuroprotective and Promotes Angiogenesis After Ischemic Stroke in Mice , 2015, ASN neuro.

[11]  A. Zekri,et al.  Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats. , 2015, European journal of pharmacology.

[12]  Xin Zhang,et al.  Human Urinary Kallidinogenase Improves Outcome of Stroke Patients by Shortening Mean Transit Time of Perfusion Magnetic Resonance Imaging. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[13]  Jing-wei Li,et al.  Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke , 2015, PloS one.

[14]  J. Y. Lee,et al.  Moyamoya Syndrome: A Window of Moyamoya Disease , 2015, Journal of Korean Neurosurgical Society.

[15]  P. Montarolo,et al.  Effects of apelin on the cardiovascular system , 2015, Heart Failure Reviews.

[16]  H. Zeng,et al.  Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes , 2014, Journal of cellular and molecular medicine.

[17]  Hong-Xia Wang,et al.  Cardioprotective effects of adipokine apelin on myocardial infarction , 2014, Heart and Vessels.

[18]  A. Akyel,et al.  Relationship between plasma apelin level and coronary collateral circulation. , 2014, Atherosclerosis.

[19]  Q. Lu,et al.  Apelin in epiretinal membranes of patients with proliferative diabetic retinopathy , 2014, Molecular vision.

[20]  Chunhua Zhu,et al.  Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways , 2014, Neuroscience Letters.

[21]  Lanfang Li,et al.  Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3. , 2014, American journal of physiology. Heart and circulatory physiology.

[22]  Chao-ke Tang,et al.  Apelin and its receptor APJ in cardiovascular diseases. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[23]  A. Imani,et al.  Post-infarct treatment with [Pyr1]-apelin-13 reduces myocardial damage through reduction of oxidative injury and nitric oxide enhancement in the rat model of myocardial infarction , 2013, Peptides.

[24]  Josef M. Penninger,et al.  Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues , 2013, Journal of the American Heart Association.

[25]  Hongxia Wang,et al.  Promoting Effects of the Adipokine, Apelin, on Diabetic Nephropathy , 2013, PloS one.

[26]  S. Nanayakkara,et al.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure , 2013, Environmental Health and Preventive Medicine.

[27]  Bo Bai,et al.  Neuroprotection of apelin and its signaling pathway , 2012, Peptides.

[28]  H. Kidoya,et al.  Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. , 2010, Blood.

[29]  I. Nagtegaal,et al.  BRAF mutation in metastatic colorectal cancer. , 2009, The New England journal of medicine.

[30]  L. Pollak.  Moyamoya disease and moyamoya syndrome. , 2009, The New England journal of medicine.

[31]  P. Vajkoczy,et al.  Increased Levels of Circulating Endothelial Progenitor Cells in Patients With Moyamoya Disease , 2009, Stroke.

[32]  M. Hirabayashi,et al.  Distribution of c-Fos immunoreactive neurons in the brain after intraperitoneal injection of apelin-12 in Wistar rats , 2008, Neuroscience Letters.

[33]  N. Mochizuki,et al.  Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis , 2008, The EMBO journal.

[34]  S. Gonidec,et al.  Apelin is a potent activator of tumour neoangiogenesis , 2007, Oncogene.

[35]  E. Mori,et al.  Risk factors for occlusive lesions of intracranial arteries in stroke‐free Japanese , 2005, European journal of neurology.

[36]  M. Fujimiya,et al.  The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism , 2001, Regulatory Peptides.

[37]  S. Hinuma,et al.  Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. , 1998, Biochemical and biophysical research communications.

[38]  J. S. Park,et al.  Neoangiogenesis of human mesenchymal stem cells transfected with peptide-loaded and gene-coated PLGA nanoparticles. , 2016, Biomaterials.

[39]  D. Dragomir-Daescu,et al.  Apelinergic system in endothelial cells and its role in angiogenesis in myocardial ischemia. , 2016, Vascular pharmacology.

[40]  L. Caplan,et al.  Intracranial atherosclerosis , 2014, The Lancet.

[41]  M. Takayasu,et al.  Role of nitric oxide in the control of cerebral microcirculation under physiological and pathological conditions. , 2000, Clinical hemorheology and microcirculation.

[42]  M. Takayasu,et al.  Role of nitric oxide in the control of cerebral microcirculation under physiological and pathological condition , 2000 .